Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Goethe University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Peking Union Medical College Hospital
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
Chinese University of Hong Kong
Goethe University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Goethe University
University of Washington
University of California, San Diego
University of California, Davis
Northwestern University
Universität des Saarlandes
Universität des Saarlandes
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
University of Maryland, Baltimore
Swiss Cancer Institute
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Washington
Asan Medical Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center